Non Cystic Fibrosis Bronchiectasis: Clinical Trials

8 trials for Non Cystic Fibrosis Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting, 1 active not recruiting, 1 terminated. 4 Phase 3, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1
Not applicable2Not yet recruiting 2

Follow Non Cystic Fibrosis Bronchiectasis: new trials by email Literature Review of Non Cystic Fibrosis Bronchiectasis trials Research Report on Non Cystic Fibrosis Bronchiectasis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HFCWO in Children With Non-CF Bronchiectasis
High Frequency Chest Wall Oscillation, conventional physiotherapy program directed towards improvement of pulmonary functions and quality of life. - Non Cystic Fibrosis Bronchiectasis
Not applicableNot yet recruitingSphinx university602026-07-012026-07-28
Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases
Videoconferencing (Vsee platform), Specially designed website (FysΑΩ) - Chronic Suppurative Lung Disease, Protracted Bacterial Bronchitis
Not applicableNot yet recruitingUniversity of Thessaly322026-05-012026-01-30
Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care
Airway clearance therapy through acoustic oscillations - Cystic Fibrosis (CF), Non Cystic Fibrosis Bronchiectasis
Active not recruitingCognita Labs LLC152024-02-172026-10-22
Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.
CMS, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3TerminatedZambon SpA2872018-01-292026-10-15
Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
Non Cystic Fibrosis Bronchiectasis
CompletedUniversity of Leeds1292017-07-012025-03-14
Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)
CMS, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedZambon SpA3772017-06-062023-11-15
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)
Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedAradigm Corporation3042014-05-282021-03-26
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)
Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedAradigm Corporation2782014-03-312021-03-26

Narrower conditions

Bronchiectasis (3)  ·  Cystic Fibrosis (2)  ·  Ciliary Motility Disorders (1)  ·  Pseudomonas Infections (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Respiratory Tract Diseases (5)  ·  Bronchial Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Digestive System Diseases (2)  ·  Infant, Newborn, Diseases (2)  ·  Lung Diseases (2)  ·  Pancreatic Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chronic Disease (1)  ·  Ciliopathies (1)  ·  Congenital Abnormalities (1)  ·  Disease Attributes (1)

Interventions

Inhalation (2)  ·  Saline Solution (2)  ·  Chest Wall Oscillation (1)  ·  Quality of Life (1)  ·  colistinmethanesulfonic acid (1)

Sponsors

Aradigm Corporation (2)  ·  Zambon SpA (2)  ·  Cognita Labs LLC (1)  ·  Sphinx university (1)  ·  University of Leeds (1)  ·  University of Thessaly (1)

Countries

Australia (4)  ·  Israel (4)  ·  Italy (4)  ·  United Kingdom (4)  ·  United States (4)  ·  Canada (3)  ·  Germany (3)  ·  Greece (3)  ·  New Zealand (3)  ·  Poland (3)  ·  Spain (3)  ·  France (2)  ·  Hungary (2)  ·  Portugal (2)  ·  Romania (2)

Top investigators

Aspasia Mavronasou, PT, MSc, PhD candidate (1)  ·  Chris Landon, M.D. (1)  ·  Eleni A Kortianou, Professor (1)  ·  Eleni Kortianou, Professor (1)  ·  Paola Castellani, MD (1)

Results publications

PMID 30658914, PMID 32554534

NIH funding

2015 (1), 2016 (1)